Elevatus Welath Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$478K Sell
2,198
-1,178
-35% -$261K 0.25% 73
2025
Q4
$771K Buy
3,376
+43
+1% +$9.79K 0.21% 75
2025
Q3
$772K Buy
3,333
+433
+15% +$88.2K 0.22% 60
2025
Q2
$538K Buy
2,900
+790
+37% +$147K 0.18% 62
2025
Q1
$442K Sell
2,110
-450
-18% -$87.5K 0.25% 57
2024
Q4
$455K Buy
2,560
+1,175
+85% +$216K 0.16% 62
2024
Q3
$274K Sell
1,385
-9,391
-87% -$1.75M 0.09% 73
2024
Q2
$1.85M Buy
10,776
+9,087
+538% +$1.51M 0.69% 42
2024
Q1
$307K Sell
1,689
-666
-28% -$115K 0.12% 70
2023
Q4
$365K Buy
2,355
+918
+64% +$134K 0.17% 62
2023
Q3
$214K Buy
+1,437
New +$211K 0.19% 63

Other funds holding ABBV